Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 3Gynecologic 2Genitourinary 2Gastrointestinal 2

Conditions

Carcinoma, Renal Cell 22Kidney Neoplasms 19Melanoma 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 7Leukemia, Lymphocytic, Chronic, B-Cell 7Hodgkin Disease 7Lymphoma, Non-Hodgkin 6Lymphoma, Follicular 6Leukemia, Myeloid, Acute 6Recurrence 5Neoplasm Metastasis 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Accelerated Phase 5Congenital Abnormalities 5Waldenstrom Macroglobulinemia 4Uterine Cervical Neoplasms 4Neoplasms, Plasma Cell 4Myeloproliferative Disorders 4Myelodysplastic Syndromes 4Lymphoma 4Leukemia 4Dendritic Cell Sarcoma, Interdigitating 4Burkitt Lymphoma 4Breast Neoplasms 4

Interventions

pembrolizumab 5fludarabine 4aldesleukin 4Cyclophosphamide 4fludarabine phosphate 2Taxes 2Polymerase Chain Reaction 2Gene Expression Profiling 2Counseling 2Bupropion 2Adoptive Transfer 2motexafin gadolinium 1entinostat 1bintrafusp alfa protein, human 1Zinc Oxide 1Vorinostat 1Varenicline 1Tobacco Use Cessation Devices 1Ritonavir 1Radiotherapy 1Psychiatric Rehabilitation 1Pemetrexed 1Paclitaxel 1Nivolumab 1Nicotine Replacement Therapy 1Nicotine 1Interleukin-2 1Indinavir 1Immunohistochemistry 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × fludarabine phosphate × Genitourinary × Clear all
NCT01585428 2018-03-07

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
29 enrolled 12 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Papillomavirus Infections

NCT02280811 2017-09-06

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
12 enrolled 19 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡